Compare Net Income Per E B T Across Equities

You can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible positions. Check out your portfolio center.

Specify up to 10 symbols:

Apply

Cross Equities Net Income Per E B T Analysis

Compare CytomX Therapeutics, Spero Therapeutics, and Neoleukin Therapeutics Net Income Per E B T Over Time

Select Fundamental

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
CTMX	1.0007	1.0007	1.0007	1.0007	1.0003	1.0003	0.9997	0.9882	1.2035	0.9958	0.7027	0.9646	0.9797	(0.1712)	(0.16)
SPRO	0.772	0.772	0.772	0.772	0.772	0.772	0.781	0.9877	0.9877	0.9877	0.9903	1.0172	1.0348	0.8977	0.74
TIL	0.9896	0.9896	0.9896	0.9896	0.9896	0.9896	0.9896	0.9896	0.9896	0.9896	1.004	1.0002	0.9908	1.14	1.1
NXTC	0.9068	0.9068	0.9068	0.9068	0.9068	0.9068	0.9068	0.9068	0.9068	0.9068	0.9068	0.9291	0.9291	0.84	0.74
ASMB	0.0	0.001	0.9862	0.9862	0.9862	0.9862	0.9862	0.8255	1.0123	0.9921	0.9578	0.9809	0.989	1.0005	0.62
ACHL	1.0001	1.0001	1.0001	1.0001	1.0001	1.0001	1.0001	1.0001	1.0001	1.0001	1.0001	1.0006	1.0016	1.0071	0.8
NUVB	0.9481	0.9481	0.9481	0.9481	0.9481	0.9481	0.9481	0.9481	0.9481	0.9481	0.9481	0.9181	0.8509	0.98	1.0
CNTB	0.9819	0.9819	0.9819	0.9819	0.9819	0.9819	0.9819	0.9819	0.9819	0.9819	1.0078	1.0013	1.0026	1.002	0.8

CytomX Therapeutics, Spero Therapeutics, and Neoleukin Therapeutics Net Income Per E B T description

Generate Optimal Portfolios

The classical approach to portfolio optimization is known as Modern Portfolio Theory (MPT). It involves categorizing the investment universe based on risk (standard deviation) and return, and then choosing the mix of investments that achieves the desired risk-versus-return tradeoff. Portfolio optimization can also be thought of as a risk-management strategy as every type of equity has a distinct return and risk characteristics as well as different systemic risks, which describes how they respond to the market at large. Macroaxis enables investors to optimize portfolios that have a mix of equities (such as stocks, funds, or ETFs) and cryptocurrencies (such as Bitcoin, Ethereum or Monero)

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	CEOs Directory Screen CEOs from public companies around the world
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Compare Net Income Per E B T Across Equities

Specify up to 10 symbols:

Cross Equities Net Income Per E B T Analysis

CytomX Therapeutics, Spero Therapeutics, and Neoleukin Therapeutics Net Income Per E B T description

Generate Optimal Portfolios

Other Complementary Tools

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY